BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15336594)

  • 1. Severe osteopenia in CFTR-null mice.
    Dif F; Marty C; Baudoin C; de Vernejoul MC; Levi G
    Bone; 2004 Sep; 35(3):595-603. PubMed ID: 15336594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth.
    Braux J; Jourdain ML; Guillaume C; Untereiner V; Piot O; Baehr A; Klymiuk N; Winter N; Berri M; Buzoni-Gatel D; Caballero I; Guillon A; Si-Tahar M; Jacquot J; Velard F
    J Cyst Fibros; 2020 May; 19(3):466-475. PubMed ID: 31787573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR deletion affects mouse osteoblasts in a gender-specific manner.
    Orlando V; Morin G; Laffont A; Lénart D; Solórzano Barrera C; Mustafy T; Sankhe S; Villemure I; Mailhot G
    J Cell Physiol; 2020 Oct; 235(10):6736-6753. PubMed ID: 31985038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Characterization and Comparison of Cystic Fibrosis Rat Models Generated Using CRISPR/Cas9 Gene Editing.
    McCarron A; Cmielewski P; Reyne N; McIntyre C; Finnie J; Craig F; Rout-Pitt N; Delhove J; Schjenken JE; Chan HY; Boog B; Knight E; Gilmore RC; O'Neal WK; Boucher RC; Parsons D; Donnelley M
    Am J Pathol; 2020 May; 190(5):977-993. PubMed ID: 32084371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFTR Modulates Hypothalamic Neuron Excitability to Maintain Female Cycle.
    Wu Y; Que Y; Chen J; Sun L; Guo J; Ruan YC
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation.
    Fonseca Ó; Gomes MS; Amorim MA; Gomes AC
    Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine Complications of Cystic Fibrosis.
    Kelly A; Marks BE; Stalvey MS
    Clin Chest Med; 2022 Dec; 43(4):773-789. PubMed ID: 36344080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis.
    Ferrari V; Terlizzi V; Stagi S
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Cells Differentiation: How CFTR Mutations May Rule the Game of Stem Cells Commitment?
    Dumortier C; Danopoulos S; Velard F; Al Alam D
    Front Cell Dev Biol; 2021; 9():611921. PubMed ID: 34026749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis.
    Putman MS; Greenblatt LB; Bruce M; Joseph T; Lee H; Sawicki G; Uluer A; Sicilian L; Neuringer I; Gordon CM; Bouxsein ML; Finkelstein JS
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1248-e1261. PubMed ID: 33258950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease.
    Robinson CA; Hofer M; Benden C; Schmid C
    J Bras Pneumol; 2019 Feb; 45(1):e20170280. PubMed ID: 30843951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat.
    Stalvey MS; Havasi V; Tuggle KL; Wang D; Birket S; Rowe SM; Sorscher EJ
    PLoS One; 2017; 12(11):e0188497. PubMed ID: 29190650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis.
    Putman MS; Greenblatt LB; Sicilian L; Uluer A; Lapey A; Sawicki G; Gordon CM; Bouxsein ML; Finkelstein JS
    Osteoporos Int; 2016 Aug; 27(8):2497-505. PubMed ID: 26952010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.
    Jacquot J; Delion M; Gangloff S; Braux J; Velard F
    Osteoporos Int; 2016 Apr; 27(4):1401-1412. PubMed ID: 26431978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice.
    Le Henaff C; Mansouri R; Modrowski D; Zarka M; Geoffroy V; Marty C; Tarantino N; Laplantine E; Marie PJ
    J Biol Chem; 2015 Jul; 290(29):18009-18017. PubMed ID: 26060255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period.
    Putman MS; Baker JF; Uluer A; Herlyn K; Lapey A; Sicilian L; Tillotson AP; Gordon CM; Merkel PA; Finkelstein JS
    J Cyst Fibros; 2015 Jul; 14(4):526-32. PubMed ID: 25698451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis.
    Putman MS; Milliren CE; Derrico N; Uluer A; Sicilian L; Lapey A; Sawicki G; Gordon CM; Bouxsein ML; Finkelstein JS
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3399-407. PubMed ID: 24926955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS; Chang AB
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002010. PubMed ID: 24627308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis-related bone disease: insights into a growing problem.
    Stalvey MS; Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):547-52. PubMed ID: 24468756
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.